Breaking News | YHLO Achieves Full IVDR CE Certification for the Blood Bank Panel 🎉— the First in China 🇨🇳🌍

Breaking News!!! We are thrilled to share a major milestone in YHLO's global regulatory journey that we have got the latest Class D IVDR CE certificate for our HIV assay! With this approval, YHLO has now achieved full IVDR CE certification for the entire Blood Bank Panel—including HIV, HBV(HBsAg, Anti-HBs, HBeAg, Anti-HBe, Anti-HBc), HCV, and Syphilis(Anti-TP).

This achievement makes YHLO the first company in China — and among the first globally — to obtain full IVDR CE certification for the Blood Bank panel.

Founded in 2008, YHLO is a national high-tech enterprise and specialized in R&D, production and sale of in vitro diagnostic (IVD) instruments and reagents. With our committed innovation, nowadays our multiple products have entered more than 120 countries.

YHLO will continue working hand-in-hand with glogal partners to build a healthier, better future together.